Literature DB >> 1057376

Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia.

M E Lippman, S Perry, E B Thompson.   

Abstract

The myeloblasts of 16 patients with untreated acute myelogenous leukemia were examined for specific glucocorticoid binding proteins. In only 3 of the 16 patients were such high affinity receptors found. The presence of glucocorticoid binding protein activity was positively correlated with inhibition of macromolecular synthesis of myeloblasts in vitro whereas absence of binding protein activity was associated with lack of glucocorticoid inhibition of the cells. Since glucocorticoids appear efficacious in only a small fraction of cases of acute myelogenous leukemia, determination of glucocorticoid binding protein activity may provide assistance in planning chemotherapeutic regimens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1057376     DOI: 10.1016/0002-9343(75)90357-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Receptor dysfunctions in human disease.

Authors:  L H Block; W Tenschert; R Locher; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1981-04-15

2.  Determination of glucocorticoid receptors in human leukemias.

Authors:  A D Ho; W Hunstein; W Schmid
Journal:  Klin Wochenschr       Date:  1980-01-02

3.  Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.

Authors:  B Lönnqvist; B Andersson; M Björkholm; L Engstedt; G Gahrton; R Hast; G Holm; A Killander; B Lantz; D Lockner; H Mellstedt; J Palmblad; C Paul; C Peterson; B Simonsson; A M Stalfelt; A M Udén; B Wadman; G Oberg
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 4.  Glucocorticoid receptors in human leukemias and related diseases.

Authors:  E B Thompson; J R Smith; S Bourgeois; J M Harmon
Journal:  Klin Wochenschr       Date:  1985-08-01

5.  Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. A Southwest Oncology Group study.

Authors:  V Gupta; E B Thompson; D Stock-Novack; S E Salmon; H I Pierce; J D Bonnet; D Chilton; J Beckford
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.